CLINICAL_TRIALS
trial_result
· 2011-10-17
Clinical Trial Update: Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia [Phase 1]
Summary
Phase 1 dose-escalation and safety study of CP-461 in patients with Chronic Lymphocytic Leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED